Five or more years of survival in patients with primary systemic amyloidosis and biopsy-proven cardiac involvement.
Survival of > or =5 years was seen in 8 of 153 patients (5%) with primary systemic amyloidosis and cardiac involvement. All patients with survival of >5 years received chemotherapy and all but 1 had an objective chemotherapeutic response.
Grogan
M
M
Division of Cardiovascular Diseases, Mayo Clinic and Foundation, Rochester, Minnesota 55901, USA.
Gertz
M A
MA
Kyle
R A
RA
Tajik
A J
AJ
D000368:Aged; D000686:Amyloidosis / Q000401:mortality* / Q000473:pathology; D001706:Biopsy; D009202:Cardiomyopathies / Q000401:mortality* / Q000473:pathology; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D009206:Myocardium / Q000473:pathology; D015996:Survival Rate; D013997:Time Factors